The NeuroStar TMS Therapy® is the first TMS treatment approved by the FDA for clinical use in the US.
For decades, researchers have sought safe and effective treatments for depression. However, there is no single depression treatment which has been proven to work for everyone.
Depression is often treated with antidepressants medications; however, alternative treatments for depression are available. These depression therapies have been shown to work in people who do not receive benefit from medications or cannot tolerate the side effects caused by them.
One alternative therapy for the treatment of depression is transcranial magnetic stimulation. NeuroStar TMS Therapy® was recently FDA-cleared for patients suffering from depression who have not achieved satisfactory improvement from prior antidepressant medications.
TMS uses short pulses of magnetic fields to stimulate nerve cells in the area of the brain thought to control mood. It is sometimes referred to as rTMS which stands for repetitive transcranial magnetic stimulation. TMS Therapy is performed in a psychiatrist’s office under their supervision while you remain awake and alert.
NeuroStar TMS Therapy® is an outpatient procedure. The typical treatment course consists of 5 treatments per week over a 4-6 week period for 20-30 treatments. Each depression treatment session lasts approximately 37 minutes.
NeuroStar TMS Therapy is:
In a controlled clinical trial comparing active treatment with the NeuroStar TMS Therapy® system to an inactive device, patients treated with active NeuroStar TMS Therapy® experienced a 22.1% average reduction of their depression symptoms, compared to a 9% average reduction of depression symptoms in patients receiving inactive treatment.
Patients treated with NeuroStar TMS Therapy® also experienced significant improvement in anxiety and physical symptoms (such as appetite changes, aches and pains, and lack of energy) associated with depression.
In a study most like real world clinical practice where all patients received active treatment, approximately half of the patients treated with NeuroStar TMS Therapy® experienced significant improvement in their depression symptoms. About a third of the patients treated with NeuroStar TMS Therapy experienced complete symptom relief at the end of six weeks.
Note: NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.
Adapted from material provided by Neuronetics, sole manufacturer of NeuroStar TMS Therapy. Used with permission.
Peter B. van Dyck, MD & Associates, PA
Office: 4601 Lake Boone Trail, Suite 1B, Raleigh, NC, 27607
Mail: PO Box 19410, Raleigh, NC 27619-9410
Tel: 919.781.1800 - Fax 919.781.1899